OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis
Lu Zhou, Peng Yu, Tingting Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Molecular mechanisms of ferroptosis and relevance to inflammation
Liyan Deng, Shasha He, Nuoqing Guo, et al.
Inflammation Research (2022) Vol. 72, Iss. 2, pp. 281-299
Open Access | Times Cited: 114

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
Qi Feng, Xiaoyue Yu, Yingjin Qiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 71

CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury
Yixin Ma, Lili Huang, Zheng Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 449-463
Open Access | Times Cited: 24

Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases
Qi Feng, Yang Yang, Kaidi Ren, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3726-3743
Open Access | Times Cited: 23

Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway
Yiwei Du, Xiao‐Kang Li, Tingting Wang, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 22

Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment
Ou Qiao, Xinyue Wang, Yuru Wang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 211-222
Open Access | Times Cited: 20

Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Life Sciences (2023) Vol. 318, pp. 121466-121466
Open Access | Times Cited: 20

Peroxynitrite activated near-infrared fluorescent probe for evaluating ferroptosis-mediated acute kidney injury
Wenjie Yang, Ruixin Liu, Xiaoyi Yin, et al.
Sensors and Actuators B Chemical (2023) Vol. 393, pp. 134180-134180
Closed Access | Times Cited: 20

SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization
Jun Deng, Xü Lin, Jiajia Qin, et al.
Redox Biology (2024) Vol. 70, pp. 103039-103039
Open Access | Times Cited: 9

Polydatin retards the progression of osteoarthritis by maintaining bone metabolicbalance and inhibiting macrophage polarization
Qi Sun, Xinyu Nan, Hui Wang, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access

Perillaldehyde ameliorates sepsis-associated acute kidney injury via inhibiting HSP90AA1-mediated ferroptosis and pyroptosis: Molecular structure and protein interaction of HSP90AA1
Shuai Liu, Yunfei Xu, Xudong Yao, et al.
International Journal of Biological Macromolecules (2025), pp. 140954-140954
Closed Access

Ferroptosis, a Rising Force against Renal Fibrosis
Yi Liu, Jingyu Wang
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 26

Emodin disrupts the Notch1/Nrf2/GPX4 antioxidant system and promotes renal cell ferroptosis
Miao Xing, Xiaoyu Ma, Xi Wang, et al.
Journal of Applied Toxicology (2023) Vol. 43, Iss. 11, pp. 1702-1718
Closed Access | Times Cited: 15

Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation
Lan Feng, Yang Chen, Ni Li, et al.
Life Sciences (2023) Vol. 322, pp. 121671-121671
Closed Access | Times Cited: 13

Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114849-114849
Open Access | Times Cited: 11

Novel Insight into Ferroptosis in Kidney Diseases
Yang Liu, Yong Liu, Sijie Zhou, et al.
American Journal of Nephrology (2023) Vol. 54, Iss. 5-6, pp. 184-199
Closed Access | Times Cited: 11

Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis—A Systematic Review
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 4

Ferroptosis: A new insight for treatment of acute kidney injury
Shiyang Li, Rui Wang, Yixue Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20

The Role of Pyroptosis in the Pathogenesis of Kidney Diseases
Zhuanli Zhou, Qin Li
Kidney Diseases (2023) Vol. 9, Iss. 6, pp. 443-458
Open Access | Times Cited: 9

Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury
Qiming Gong, Tengfang Lai, Liudan Liang, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 8

Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway
Jiabin Wu, Ke Li, Muge Zhou, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100946-100946
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top